Brolucizumab clinical and safety outcomes in a neovascular age-related macular degeneration national database: Fight Retinal Blindness Spain (FRB Spain).

Saved in:
Bibliographic Details
Title: Brolucizumab clinical and safety outcomes in a neovascular age-related macular degeneration national database: Fight Retinal Blindness Spain (FRB Spain).
Authors: Zarranz-Ventura J; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. zarranz@clinic.cat.; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. zarranz@clinic.cat., Marías-Pérez S; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., Martin-Pinardel R; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Fernandez-Bonet M; Hospital Dos de Maig, Barcelona, Spain., Pina-Marin B; Hospital Dos de Maig, Barcelona, Spain., Cobos E; Hospital Universitari de Bellvitge, Hospitalet del Llobregat, Barcelona, Spain., Rodríguez-Fernandez CA; Hospital Universitari de Bellvitge, Hospitalet del Llobregat, Barcelona, Spain., Parrado-Carrillo A; Hospital del Mar, Barcelona, Spain., Alarcón-Valero I; Hospital del Mar, Barcelona, Spain., Barnes C; Hospital Consorci Sanitari Moises Broggi, Sant Joan Despí, Spain., Cilveti E; Hospital Consorci Sanitari Moises Broggi, Sant Joan Despí, Spain., Aramburu-Claveria J; Hospital Clínico Universitario Lozano Blesa; Aragón Health Research Institute (IIS-Aragón); School of Medicine, University of Zaragoza, Zaragoza, Spain., Ascaso-Puyuelo FJ; Hospital Clínico Universitario Lozano Blesa; Aragón Health Research Institute (IIS-Aragón); School of Medicine, University of Zaragoza, Zaragoza, Spain., Calvo P; Miguel Servet Ophthalmology Research Group (GIMSO), Miguel Servet University Hospital, Aragón Institute for Health Research (IIS-Aragón), Zaragoza, Spain., Ruiz-Del-Tiempo MP; Miguel Servet Ophthalmology Research Group (GIMSO), Miguel Servet University Hospital, Aragón Institute for Health Research (IIS-Aragón), Zaragoza, Spain., Susanna-González G; Medical Department, Novartis Farmacéutica SA, Barcelona, Spain., Figueras-Roca M; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Casaroli-Marano RP; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Department of Surgery, School of Medicine, University of Barcelona, Barcelona, Spain., Bernal-Morales C; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Corporate Authors: Fight Retinal Blindness Spain (FRB Spain) investigators
Source: Eye (London, England) [Eye (Lond)] 2025 Aug; Vol. 39 (12), pp. 2407-2414. Date of Electronic Publication: 2025 Jun 05.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5454
DOI:10.1038/s41433-025-03871-6